Pharmaceuticals News and Research

RSS

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.

25 Nov 2015

Novartis announces EC approval of Cosentyx for treatment of ankylosing spondylitis, psoriatic arthritis

Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.

25 Nov 2015

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

Mylan N.V. today announced the U.S. launch of Clozapine Orally Disintegrating Tablets, 25 mg and 100 mg, the generic version of Jazz Pharmaceutical's FazaClo.

24 Nov 2015

Green Cross' Biologics License Application for IVIG-SN submitted to FDA

Green Cross Corporation, a South Korean biopharmaceutical company, today announced that it has submitted its Biologics License Application for IVIG-SN (human normal immunoglobulin G for intravenous administration) to the United States Food and Drug Administration.

24 Nov 2015

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

23 Nov 2015

New drug screening method may predict treatment options for patients with multiple myeloma

A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer. The process, developed by scientists at Washington University School of Medicine in St. Louis, also may aid patients with leukemia or lymphoma.

21 Nov 2015

Ninlaro (ixazomib) approved to treat people with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy.

21 Nov 2015

New Berman Airways from Qosina

Qosina is pleased to announce the addition of a new line of Berman Airways (#50114 - #50121), in stock and ready for immediate delivery.

20 Nov 2015

New data shows ALS-008176 drug safe and effective against RSV infection

Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies announced that the New England Journal of Medicine will publish findings from a respiratory syncytial virus (RSV) challenge study for ALS-008176, a cytidine nucleoside analog with activity against RSV.

20 Nov 2015

Health experts urge lawmakers, regulators to close loopholes in Orphan Drug Act

Health experts at Johns Hopkins Medicine are calling on lawmakers and regulators to close loopholes in the Orphan Drug Act they claim give drug companies millions of dollars in unintended and misplaced subsidies and tax breaks and fuel skyrocketing medication costs.

20 Nov 2015

New Series urges renewed focus to combat antimicrobial resistance, highlights lack of access to antimicrobial drugs

The global fight against antimicrobial resistance could be under threat unless the evidence base for policies to control resistance is radically improved, according to a major new Series, published in The Lancet.

20 Nov 2015

Global tissue engineered medical devices market expected to cross US$ 26 billion by 2020

According to recently published Pharmaion report, "Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020", global tissue engineered medical devices market is anticipated to cross US$ 26 billion by 2020.

19 Nov 2015

Medical researchers use social media to study harmful side effects of narcotics medication

Harnessing the power of social media, medical researchers have sifted through more than two billion tweets and online posts to study the harmful side effects of narcotics medication taken for chronic pain.

19 Nov 2015

Two Loyola professors explore ethical issues that arise with use of social media in health care

In a recent AMA Journal of Ethics article titled "Why Can't We Be Friends? A Case-Based Analysis of Ethical Issues with Social Media in Health Care," two Loyola University Chicago Stritch School of Medicine professors analyze this issue. Kayhan Parsi, JD, PhD, and Nanette Elster, JD, MPH, who are part of Loyola's Neiswanger Institute for Bioethics, discuss the good, the bad, and the ugly of social media and health care.

19 Nov 2015

New drug combination may reduce need for complex regimens to treat hepatitis C

The prognosis for people with hepatitis C has improved dramatically in the last few years, thanks to the introduction of direct-acting anti-viral medications, including Harvoni (the brand name for a combination of ledipasvir and sofosbuvir) and Viekira Pack (a mix of ombitasvir, paritaprevir, ritonavir and dasabuvir).

19 Nov 2015

New insulin pill shows promise as novel form of therapy for diabetes

An insulin pill being developed by researchers at UC Santa Barbara may in the near future give another blood sugar management option to those who suffer from diabetes. The novel drug delivery technology may also apply to a wide spectrum of other therapies.

19 Nov 2015

NIAID launches major initiative to advance novel approaches to treat, prevent HIV infections

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, launched a major initiative to advance novel approaches to treat and prevent HIV infections based on broadly neutralizing antibodies (bNAbs) today.

19 Nov 2015

Cherwell selected for quality and service in environmental monitoring by Portsmouth PMU

Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, has been assisting Portsmouth Pharmaceutical Manufacturing Unit (PMU) in their extensive environmental monitoring (EM) programme for over 20 years

From Cherwell Laboratories 18 Nov 2015

PTI explains strength and BCS-based biowaivers

Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.

From Pharmaceutical Training International 18 Nov 2015

Promising new treatment for sepsis on the horizon

A promising new drug for sepsis is on the horizon thanks to new funding from the British Heart Foundation, which could help take the laboratory discovery into the clinic.

18 Nov 2015

Pharmaceuticals News and Research

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Novartis announces EC approval of Cosentyx for treatment of ankylosing spondylitis, psoriatic arthritis

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

Green Cross' Biologics License Application for IVIG-SN submitted to FDA

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

New drug screening method may predict treatment options for patients with multiple myeloma

Ninlaro (ixazomib) approved to treat people with multiple myeloma

New Berman Airways from Qosina

New data shows ALS-008176 drug safe and effective against RSV infection

Health experts urge lawmakers, regulators to close loopholes in Orphan Drug Act

New Series urges renewed focus to combat antimicrobial resistance, highlights lack of access to antimicrobial drugs

Global tissue engineered medical devices market expected to cross US$ 26 billion by 2020

Medical researchers use social media to study harmful side effects of narcotics medication

Two Loyola professors explore ethical issues that arise with use of social media in health care

New drug combination may reduce need for complex regimens to treat hepatitis C

New insulin pill shows promise as novel form of therapy for diabetes

NIAID launches major initiative to advance novel approaches to treat, prevent HIV infections

Cherwell selected for quality and service in environmental monitoring by Portsmouth PMU

PTI explains strength and BCS-based biowaivers

Promising new treatment for sepsis on the horizon

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring